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a b s t r a c t 
Obesity is a primary risk factor for numerous metabolic diseases including metabolic syndrome, type II 
diabetes (T2DM), cardiovascular disease and cancer. Although classically viewed as a storage organ, the ﬁeld 
of white adipose tissue biology is expanding to include the consideration of the tissue as an endocrine organ
and major contributor to overall metabolism. Given its role in energy production, the mitochondrion has 
long been a focus of study in metabolic dysfunction and a link between the organelle and white adipose
tissue function is likely. Herein, we present a novel method for assessing mitochondrial bioenergetics from 
whole white adipose tissue. This method requires minimal manipulation of tissue, and eliminates the need 
for cell isolation and culture. Additionally, this method overcomes some of the limitations to working with 
transformed and / or isolated primary cells and allows for results to be obtained more expediently. In addition
to the novel method, we present a comprehensive statistical analysis of bioenergetic data as well as guidelines 
for outlier analysis. 
c © 2014 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-SA license 
( http: // creativecommons.org / licenses / by-nc-sa / 3.0 / ). ntroduction 
Metabolic syndrome is a growing epidemic in the United States 
nd worldwide. Currently, approximately 34% of the US population 
re living with this diagnosis [ 1 , 2 ] and it is expected that this number 
ill continue to increase. By 2030, it is anticipated that the ﬁnancial 
urden of healthcare for patients requiring treatment for diabetes, 
eart and stroke will be $48–66 billion annually [ 3 ]. One of the hall- 
arks of metabolic syndrome is central obesity, an increase in visceral 
hite adipose tissue (WAT) around the midsection. Central obesity 
ot only contributes to metabolic syndrome but also increases indi- 
idual risk for type II diabetes mellitus (T2DM) and cardiovascular 
isease (CVD) [ 4 ]. 
WAT has classically been viewed as a storage organ, containing 
etabolic substrates in the form of triglycerides as well as insulation 
nd cushioning for the internal organs [ 5 ]. A more contemporary per- 
pective that has surfaced over the last decade is one of WAT being an 
ndocrine organ and a major factor in metabolism and homeostasis 
 6 –9 ]. For example, in addition to triglyceride storage, WAT secretes 
umerous hormones and cytokines (adiponectin, leptin, TNF- α, etc.) 1 These authors contributed equally to this work. 
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ttp://dx.doi.org/10.1016/j.redox.2014.04.005 [ 9 ]. Coupled with this viewpoint of WAT is the hypothesis that numer- 
ous cardiometabolic pathologies have mitochondrial dysfunction as a 
contributing factor [ 10 –13 ]. Mitochondria are central to metabolism, 
yet prone to damage that can adversely affect their function [ 14 , 15 ]. 
The assessment of mitochondrial function in WAT has been identiﬁed 
as a key target for T2D and obesity [ 16 ] and current studies utilize 
both isolated adipocyte mitochondria [ 17 ], immortalized adipocyte 
cell lines [ 18 ], and isolated primary cells [ 19 ]. Isolation of mitochon- 
dria from WAT requires multiple steps and results in measures of 
organelle function in the absence of its native cellular environment. 
Also, functional measures of immortalized / isolated cells that have 
been manipulated to allow for multiple passages may substantially al- 
ter aspects of mitochondrial function. A method for direct assessment 
of mitochondrial function from whole WAT would provide an alterna- 
tive or complementary approach for exploring adipose bioenergetics. 
In this regard, methods for mitochondrial bioenergetic measurement 
from whole adipose tissue have been previously reported [ 20 , 21 ] but 
have certain limitations in that certain parameters of mitochondrial 
function could not be deﬁned. 
A methodology herein is provided that utilizes minimal amounts 
of tissue and increased number of timepoint collections to ensure 
tissue equilibration. This approach allowed the measurement of ad- 
ditional parameters of mitochondrial function including ATP-linked, 
maximal oxygen consumption and reserve capacity. Additionally, a 
reproducible data ﬁltering method was employed to account for 
among replicate variance often seen when analyzing whole tissue  access article under the CC BY-NC-SA license ( http: // creativecommons.org / licenses / 










































































































 samples (relative to isolated cells or mitochondria), presumably due
to differential absorptive properties of whole tissue versus isolated
cells. Therefore, the utility of the methodology and approach pre-
sented should aide those interested in evaluating raw bioenergetic
data obtained from whole tissues including WAT. 
For these studies, mitochondrial bioenergetics was compared be-
tween two WAT depots, inguinal (iWAT) and epididymal (eWAT) from
C57BL6 / J mice; a mouse model classically used as a control for car-
diovascular and metabolic disease studies. 
Methods 
Acquisition and preparation of adipose tissue 
12-Week old male C57BL6 / J mice were anesthetized by step-wise
chloral hydrate overdose and euthanized via removal of the heart
and exsanguination. The Institutional Animal Care and Use Commit-
tee (IACUC) of the University of Alabama at Birmingham approved
all procedures involving animals. Inguinal (iWAT) and epididymal
(eWAT) adipose depots were excised and placed in small petri dishes
with “rinse media” comprised of DMEM with 25 mM glucose and
25 mM HEPES. Tissue was gently agitated to remove hair and blood
and placed in clean rinse media. Each fat pad was sampled six times
using a 2 mm UniCore Harris Punch (Whatman, Piscataway, NJ), re-
sulting in 2 mg tissue samples. Attention was made to avoid any visi-
ble microvasculature during sampling and tissue punches were taken
from the same section of tissue as close together as possible. Tissue
punches were kept in fresh rinse media until application to an XF24
Islet Capture Microplate (Seahorse Bioscience, North Billerica, MA). 
Application of tissue to assay plate 
An XF24 Islet Capture Microplate Screen was loaded onto the
Screen Applicator Tool and the tool was positioned with the screen
facing up. A total of 4 mg of tissue (2 tissue punches) from each fat
pad were placed onto the screen with forceps, resulting in three tissue
replicates per fat pad. The screen was then snapped into the appropri-
ate well of the Islet Microplate. Rinse media was added to each well
after application of the tissue and screen. After applying all tissue
samples and rinse media, each well was rinsed two additional times.
After removal of the ﬁnal rinse, running media (DMEM with 25 mM
glucose and without HEPES) was added and removed to remove any
remaining rinse media. Finally, 450 μL of running media was added
to all sample and control wells. 
Mitochondrial effectors 
After a series of titration experiments for each mitochondrial ef-
fector, the following working concentrations were determined to
elicit maximal responses: 8 μg / mL oligomycin, 8 μM FCCP (carbonyl
cyanide p -triﬂuoromethoxyphenylhydrazone), 12 μM antimycin A
(AA), and 3 μM rotenone (Rote). The effects of these mitochondrial in-
hibitors on oxygen consumption rate (OCR –pmol oxygen per minute)
were assessed approximately 1 h after commencement of basal oxy-
gen consumption measurements. After multiple test experiments, the
number of basal measurements was increased to both allow for tissue
settling and equilibration on the islet capture microplate. 
XF24 Extracellular Flux Analyzer raw data output was transformed
to OCR using the “Level (Direct) Akos” algorithm in a middle point
mode, as previously described [ 22 ]. Cellular bioenergetic parameters
including ATP- and non-ATP- linked oxygen consumption as well as
maximal oxygen consumption and reserve capacity were calculated
as previously described [ 23 ]. Brieﬂy, ATP-linked oxygen consumption
was calculated as the difference between basal oxygen consumption
and OCR measured after the addition of oligomycin to inhibit complexV (ATP synthase). Non-ATP- linked oxygen consumption was the re-
mainder of the basal OCR (minus the AA / Rote minimum rate which
is deﬁned as non-mitochondrial oxygen utilization). Maximal OCR
was determined by subtracting the AA / Rote minimum reading from
the maximal reading following addition of FCCP. Reserve capacity
(or, spare respiratory capacity) is calculated by subtracting the basal
oxygen consumption rate (respiration rate prior to addition of com-
pounds) from the maximal oxygen consumption after the addition
of FCCP (potential maximum respiratory capacity). It is hypothesized
that reserve capacity exists as a compensation mechanism for cells
when presented with increased workload or as a stress response [ 23 ].
A sample OCR trace from WAT is shown in Fig. 1 . 
Data summarization and exploratory observations 
Raw OCR trace ﬁles were grouped according to eWAT and iWAT,
and visualized using Microsoft Excel 2011. Trace data from each sam-
ple was divided into ﬁve time periods, from which seven OCR vari-
ables were calculated (basal, mitochondrial, non-mitochondrial, ATP
linked, non-ATP linked, maximum, and reserve capacity) ( Fig. 1 ). Each
OCR measurement consisted of 3 min of mixing; 2 min wait time and
3 min of continuous measuring of O 2 levels. OCR values correspond-
ing to the equilibration period were ignored, due to physiological
acclimation of the tissues to the well microenvironment. OCR values
and slopes for each time period were summarized as the mean value
across measurements, and the coefﬁcient of least-squares regression,
in order to assess the distribution of variance among samples. 
Quality control 
Exploratory observations of reserve capacity revealed a high de-
gree of variance among OCR values within eWAT and iWAT data
sets ( Table 1 ). Reserve capacity was selected as the ﬁrst variable to
analyze as a result of the maximal oxygen consumption being the
most discriminatory during analysis of experiment success. To test
whether this variance represented biological (among sample) vari-
ance, or methodological imprecision (among replicates), single fac-
tor ANOVAs were conducted on both groups using individual mouse
identiﬁcation number as the explanatory categorical variable. For this
and all subsequent statistical analyses, a signiﬁcance level ( α) of 0.05
was assumed. The ANOVA failed to detect a signiﬁcant individual
(mouse) effect on reserve capacity in the eWAT ( p > 0.4) and iWAT
( p > 0.4) groups ( Fig. 2 ). The effect of well position on the XF-24 plate
was also evaluated as a possible source of measurement bias, and an
ANOVA was conducted on pooled trace data using well number as
the explanatory variable. This analysis also failed to detect a signiﬁ-
cant effect on reserve capacity ( p > 0.8). Together, the ANOVA results
suggested that a majority of among-replicate variance in basal slope
could not be explained by the well position on the XF-24 plate or
variation among animals. Therefore it was surmised that the majority
of observed variance is the product of some unanticipated source of
methodological imprecision, which is a potential source of noise that
may impede detection of real biological patterns. 
Consequently, it was necessary to ﬁlter data according to a classiﬁ-
cation method that would differentiate acceptable and unacceptable
samples. Replicate traces for each mouse were ranked by reserve
capacity, and pooled by rank (e.g. “maximum”, “median”, and “min-
imum”). Reserve capacity values were pooled according to rank to
compare distribution parameters (symmetry, kurtosis, skew, etc.).
Exploratory analyses identiﬁed a heavy tailed distribution and un-
acceptable coefﬁcient of variation for pooled reserve capacity data,
which was likely due to bias in the minimum group ( Table 2 ). This
suggested that a majority of samples with the lowest reserve capac-
ity measurements were affected by nonrandom effects, interpreted
here as interference from unidentiﬁed non-biological factors. Right
skewed data presents a challenge for certain classiﬁcation schemes,
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Fig. 1. Example trace from a single XF24 well depicting oxygen consumption rate of C57 iWAT. Bioenergetic parameters including basal, ATP-linked and maximal oxygen 
consumption as well as reserve capacity are outlined on the trace with corresponding mitochondrial effectors. 
Table 1 
Raw OCR data from eWAT and iWAT. 
eWAT iWAT Pooled 
N 13 13 26 
Basal OCR 168.66 ± 47.56 200.27 ± 102.32 184.46 ± 79.82 
Maximum 287.28 ± 97.25 333.32 ± 178.42 310.3 ± 142.73 
Non-mitochondrial 77.67 ± 32.45 103.53 ± 51 90.6 ± 43.91 
Mitochondrial 209.6 ± 92.57 229.8 ± 155.74 219.7 ± 125.94 
Non-ATP-linked 125.92 ± 44.94 158.84 ± 98.32 142.38 ± 76.76 
ATP-linked 42.73 ± 35.28 41.43 ± 28.69 42.08 ± 31.51 
Reserve capacity 118.62 ± 80.88 133.05 ± 90.24 125.84 ± 84.28 
Description: Table summarizing comparison of mean OCR values between raw eWAT and iWAT composite trace data sets. Data represent mean ± standard deviation. All values 
in pmol / min. 
Fig. 2. Reserve capacity as measured for replicate eWAT (hollow markers) and iWAT 
(ﬁlled markers) samples, grouped by mouse. No signiﬁcant differences were found 
between individual mice. Samples within shaded area were omitted from analyses, 




auch as Jenk ’ s natural breaks, which seeks to decrease variance within 
eplicates and maximize the variance between replicates, but is less 
ensitive to the hierarchy underlying heavy tailed data [ 24 ]. 
In contrast, a relatively new technique, head / tail breaks, is suit- 
ble for data with this distribution because it emphasizes differences among less frequent observations. The algorithm is described in detail 
by Jiang [ 25 ], but the concept is as follows. The mean value among 
the data set is used to partition the data into two parts (the “head”
and “tail”), and the procedure is iterated until the head values are no 
longer heavy tailed. In this case, no further iterations were conducted 
after the mean and median of the head group differed by less than 10%. 
The second iteration effectively reduced right skew in the minimum 
and median rank groups, providing a reserve capacity cutoff value 
(58.11 pmol / min). Samples falling below this value were suspected 
to have been inﬂuenced by methodological imprecision and omitted 
from further analysis. Composite OCR traces (eWAT and iWAT) for 
each mouse was calculated using values averaged across the ﬁltered 
data set. Composite traces were used in comparative analyses. 
Comparison of OCR between fat pads and with other tissue types 
When pooled across both fat pads, the mean reserve capacity 
(FCCP-basal) (204.96 ± 120.34 pmol / min) was lower than values 
reported for single muscle ﬁbers [ 26 ], but similar to values re- 
ported for isolated brown adipocytes [ 27 ]. A two-tailed t -test as- 
suming equal variance did not detect a signiﬁcant difference be- 
tween eWAT (204.9 ± 102.00 pmol / min) and iWAT reserve capacity 
(205.02 ± 142.89 pmol / min, p > 0.89) ( Table 3 ). 
In addition to these comparisons, it is important to note that 
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Table 2 
Relative variance and normality of raw and ﬁltered data sets. 
N Cv PPCC 
Raw respiration data 
Maximum 26 0 .61 0 .97 
Median 26 0 .84 0 .97 
Minimum 26 1 .84 0 .96 
Filtered respiration data 
Maximum 24 0 .55 0 .96 
Median 16 0 .47 0 .96 
Minimum 9 0 .47 0 .94 
Description: Table summarizing relative variance and normality compared between raw and ﬁltered trace data setsCv – coefﬁcient of variation and PPCC – normal probability plot 
correlation coefﬁcient. 
Table 3 
Filtered OCR data from eWAT and iWAT. 
eWAT iWAT Pooled 
N 12 11 23 
Basal OCR 190.97 ± 57.65 221.43 ± 97.02 205.54 ± 78.63 
Maximum 395.86 ± 131.33 426.45 ± 200.23 410.49 ± 164.59 
Non-mitochondrial 75.28 ± 39.91 120.48 ± 57.31 96.9 ± 53.13 
Mitochondrial 320.58 ± 122.40 305.97 ± 172.23 313.59 ± 145.02 
Non-ATP-linked 145.1 ± 59.05 186.54 ± 85.01 164.92 ± 74 
ATP-linked 45.87 ± 42.55 34.88 ± 24.22 40.62 ± 34.69 
Reserve capacity 204.9 ± 102.00 205.02 ± 142.89 204.96 ± 120.34 
Description: Table summarizing comparison of mean OCR values between ﬁltered eWAT and iWAT composite trace data sets. Data represent mean ± standard deviation. All values 




































































 looking at WAT in a disease state presents the unique challenge of
macrophage inﬁltration wherein a large portion of adipose tissue
may be macrophages [ 28 ]. Under these conditions, it is likely that
OCR values will be signiﬁcantly different than those where there is
not an abundance of macrophages. Mounier et al. report OCRs that
are orders of magnitude higher than those reported herein from WAT
[ 29 ], even after those results were normalized to protein levels. This
suggests that during initial screening of data, it will be evident that
the dominant cell population in any particular well is not WAT, but
is in fact inﬂammatory cells. Under these circumstances, it may be
necessary to normalize bioenergetic data not only to an adipose tis-
sue marker, but also a macrophage marker. Additionally, histological /
immunohistochemical and gene expression analyses may also be war-
ranted. 
Discussion and conclusions 
With obesity and metabolic disease incidence on the rise world-
wide, a greater understanding of adipose tissue energetics and its
contributions to whole body metabolism is needed. The goal of this
study was to develop a reliable method for assessing mitochondrial
bioenergetics from whole white adipose tissue by obtaining the great-
est amount of information with a minimal amount of tissue. 
Herein, we report the development of a method that allows the
assessment of oxygen utilization in both visceral and subcutaneous
adipose tissue in mice. In these analyses comparing bioenergetic pro-
ﬁles between fat pad tissues derived from C57BL6 / J mice, we found
no signiﬁcant differences between tissues obtained from epididymal
(visceral) and inguinal (subcutaneous) sources of fat. This result how-
ever is not surprising, as the animals used in this study were fed
a standard chow diet and were considered lean at the time of tis-
sue harvest. Since the animals did not have signiﬁcant levels of WAT
deposition and were not considered obese, the lack of variation be-
tween subcutaneous and visceral adipose tissue was not unexpected.
It is possible that introducing additional variables such as a change in
diet would alter the bioenergetics of WAT. 
In circumstances where the adipose tissue is from a disease state,
such as obesity, where the adipocytes are likely to be hypertrophic[ 30 , 31 ], an additional normalization would be required. Since larger
cells (and therefore, fewer mitochondria) would comprise the same
tissue explant, it is reasonable to assume that bioenergetics would
be altered. In these cases, one could normalize all bioenergetic data
to relative mtDNA copy number using a method described by West-
brook et al. [ 32 ]. The data described herein was normalized to relative
mtDNA copy number, though copy number was not different between
iWAT and eWAT of lean C57BL6 / J mice (data not shown). 
Additionally, the results presented herein represent one strain of
laboratory mouse and consequently, are limited in scope. However,
the primary aim of this study was to establish a method for assess-
ing bioenergetics, and the method development was successful. The
method presented herein is speciﬁc to iWAT and eWAT of lean, chow-
fed C57BL6 / J mice and should be interpreted as speciﬁc to both the
strain of mouse and fat pad. All response rates were determined dur-
ing titration and time-course experiments for each effector and the
optimal number of measurements were determined and utilized in
the ﬁnal described method. These titration and time-course experi-
ments (data not shown) allowed for stabilization of OCR after each
effector was added. Once stabilization was observed, the time of sta-
bilization was noted and the ﬁnal method was shortened so experi-
ments were not unnecessarily long. A lag is present after injection of
oligomycin (see Fig. 1 ) to account for variation in stabilization time
not observed with FCCP or Antimycin A / Rotenone. The authors rec-
ommend that both titration and time-course experiments for each
effector be performed when using the method herein on any tissue
or animal model other than iWAT / eWAT from lean C57BL6 / J mice. 
This method is distinct from previously published methodologies
for whole adipose tissue bioenergetics. These changes included: (1)
reducing the amount of tissue required per well from 10 to 2 mg in
order to reduce sample consumption as well as increase the likeli-
hood of saturating tissue with effectors after injection; (2) increasing
the number of DMEM rinses prior to loading plate into XF24 to en-
sure removal of all free lipid released during application of tissue to
microplate; (3) increasing the number of timepoints for both basal
as well as post-injection measurements to allow for maximum tissue
equilibration as well as permeation of effectors into tissue; and (4)
increasing the concentration of all mitochondrial effectors used both






























Ro acquire an oligomycin-induced response previously unreported as 
ell as to ensure robust response in response to other effectors. (5) 
mploying a reproducible data ﬁltering method to account for among 
eplicate variance in respiration rate. 
We thought a more comprehensive and regimented approach for 
mplementing data quality control prior to comparative analyses was 
ecessary for these studies due to the anticipated degree of impreci- 
ion observed for whole tissue samples, likely reﬂective of the differ- 
ntial absorptive properties of intact adipose tissue plugs compared to 
hose reported for studies using isolated cells or mitochondria. As this 
nconsistency could obfuscate biological differences among individ- 
als and tissue types, a novel ﬁltering method was used to eliminate 
nacceptable runs from the data set. In this study, reserve capacity 
as selected as the sample exclusion criterion, but the method could 
e applied to any measurement that exhibits unacceptable variance 
mong replicates (e.g. basal OCR, ATP-linked OCR, etc.). All data ﬁlter- 
ng methods suffer from some degree of subjectivity or bias, and the 
pproach used here is not intended to represent the ideal or universal 
echnique. The head / tail breaks technique is conceptually transpar- 
nt, easily reproducible, and particularly well suited to right skewed 
ata. Therefore, respirometry researchers who obtain raw data with a 
omparable degree of unexplained variance among replicates should 
onsider this ﬁltering method before conducting comparative analy- 
es. 
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